000 | 01002 a2200277 4500 | ||
---|---|---|---|
005 | 20250511184201.0 | ||
264 | 0 | _c19921217 | |
008 | 199212s 0 0 eng d | ||
022 | _a0036-8075 | ||
024 | 7 |
_a10.1126/science.1439814 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCohen, J | |
245 | 0 | 0 |
_aAIDS funding. MicroGeneSys vaccine trial gets a public peer review. _h[electronic resource] |
260 |
_bScience (New York, N.Y.) _cNov 1992 |
||
300 |
_a1079-80 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; News | ||
650 | 0 | 4 |
_aAIDS Vaccines _xtherapeutic use |
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xprevention & control |
650 | 0 | 4 | _aFinancing, Government |
650 | 0 | 4 |
_aHIV _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aVaccines, Synthetic _xtherapeutic use |
773 | 0 |
_tScience (New York, N.Y.) _gvol. 258 _gno. 5085 _gp. 1079-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.1439814 _zAvailable from publisher's website |
999 |
_c1446303 _d1446303 |